Fig. 8

Sensitivity analysis (IC50) of drugs between high- and low-LRS groups. (A-I) Docetaxel, Cisplatin, Cyclophosphamide, Lapatinib, Dinaciclib, Ribociclib, Palbociclib, Mitoxantrone. * P < 0.05; ** P < 0.01; *** P < 0.001; **** P < 0.0001.